Table 1.

Baseline characteristics of the study population.

Parameter	GnRH agonist	GnRH antagonist	n	p*
Age	35.7 ± 4.3 years	35.8 ± 4.0 years	49	0.94
AMH	3.09 ± 2.69 (0.7–14.8) ng/ml		43
BMI	22.98 ± 3.86 (17.58–33.30) kg/m2		48
Smoking	6		48
Protocol	GnRH agonist followed by GnRH antagonist: n = 31		49
	GnRH antagonist followed by GnRH agonist: n = 18
IVF	11	9	20
ICSI	33	34	67
Splitting IVF/ICSI	2	3	5
TESE-ICSI	3	3	6

^*Mann-Whitney U Test asymptotic significance (2-tailed).